Heron Therapeutics, Inc 10-K for FY2025
Heron Therapeutics, Inc. (HRTX)
10-K
2026-02-26
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
Heron Therapeutics, Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $154.9M
- up 7.4% from $144.29M a year earlier
- Net loss
- $20.2M
- compared with a net loss of $13.58M a year earlier
- Diluted EPS
- -$0.12
- compared with -$0.09 a year earlier